Overweight and Obesity and Progression of ADPKD.

Clinical Journal of the American Society of Nephrology : CJASN
Kristen L NowakMichel Chonchol

Abstract

On the basis of earlier observations, we evaluated the association between overweight and obesity and rapid progression of autosomal dominant polycystic kidney disease in participants in the Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes (TEMPO) 3:4 trial. More importantly, we also determined whether efficacy of tolvaptan was attenuated in individuals with baseline overweight or obesity. A total of 1312 study participants with relatively early-stage autosomal dominant polycystic kidney disease (mean eGFR 78±22 ml/min per 1.73 m2) who were at high risk of rapid progression were categorized by body mass index (BMI; calculated using nonkidney weight) as normal weight (18.5-24.9 kg/m2; n=670), overweight (25.0-29.9 kg/m2; n=429), or obese (≥30 kg/m2; n=213). Linear and multinomial logistic regression models were used to determine the association of baseline overweight and obesity with change in total kidney volume (TKV) over the 3-year study period. In fully adjusted models, higher BMI was associated with greater annual percent change in TKV (difference of 1.20 [95% confidence interval (95% CI), 0.85 to 1.55] per five-unit higher BMI). Overweight and obesity were associa...Continue Reading

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
May 19, 2006·The New England Journal of Medicine·Jared J GranthamUNKNOWN CRISP Investigators
Aug 16, 2006·Annals of Internal Medicine·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Apr 25, 2007·Trends in Molecular Medicine·Stephen G DannGeorge Thomas
Apr 29, 2008·Molecular Cell·Dana M GwinnReuben J Shaw
Apr 11, 2009·Transplantation Proceedings·M N Hall
May 8, 2009·American Journal of Physiology. Cell Physiology·J Darwin KingKenneth R Hallows
Feb 22, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Vicente E TorresFrank S Czerwiec
Jul 22, 2011·Trends in Molecular Medicine·Oxana Ibraghimov-Beskrovnaya, Thomas A Natoli
Aug 16, 2011·Physiology·Carles Cantó, Johan Auwerx
Nov 19, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·J Chen
Feb 22, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Arlene B ChapmanJared J Grantham
Mar 28, 2012·Clinical Pharmacokinetics·Margreke J E BrillCatherijne A J Knibbe
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
May 23, 2012·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S EnhörningO Melander
Nov 6, 2012·The New England Journal of Medicine·Vicente E TorresUNKNOWN TEMPO 3:4 Trial Investigators
Sep 26, 2014·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Guanghong JiaJames R Sowers
Nov 18, 2014·The New England Journal of Medicine·Robert W SchrierUNKNOWN HALT-PKD Trial Investigators
Nov 6, 2015·Journal of the American Society of Nephrology : JASN·Gina WarnerEduardo N Chini
Jan 15, 2016·American Journal of Physiology. Renal Physiology·Kevin R KippThomas Weimbs
Mar 24, 2016·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·K C Lewandowski, G Brabant
Apr 6, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Vicente E TorresUNKNOWN TEMPO 4:4 Trial Investigators
Oct 11, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Emilie Cornec-Le GallPeter C Harris
Nov 10, 2017·Journal of the American Society of Nephrology : JASN·Kristen L NowakMichel Chonchol
Mar 23, 2019·Kidney International·Ron T GansevoortUNKNOWN TEMPO 3:4 Investigators
Feb 23, 2020·Clinical Journal of the American Society of Nephrology : CJASN·Kristen L Nowak, Katharina Hopp

❮ Previous
Next ❯

Citations

Jun 13, 2021·Clinical Journal of the American Society of Nephrology : CJASN·Maatje D A van Gastel, Esther Meijer
Jul 16, 2021·Current Opinion in Nephrology and Hypertension·Esther Meijer, Ron T Gansevoort

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.